trans-Pinocarveol is a pinene-derived oxygenated monoterpene alcohol found in several coniferous, resinous, and seed-spice essential oils in the AromaForge archive, including cistus, galbanum, labdanum, sunflower flower, and other pinene-rich materials. The evidence base is stronger for identity, occurrence, and hazard classification than for standalone wellness pharmacology. Public studies do show antimicrobial, antioxidant, phytotoxic, or cytotoxic activity in essential oils where trans-pinocarveol is a notable component, but those findings are mixture-level and should not be presented as direct effects of isolated trans-pinocarveol.
Chemical identity and composition
PubChem lists trans-Pinocarveol as C10H16O with InChIKey LCYXQUJDODZYIJ-VGMNWLOBSA-N. It is a bicyclic monoterpene alcohol structurally linked to pinene oxidation chemistry. In the local archive it appears at notable levels in labdanum rockrose (3.69%), cistus (0.99-1.59%), galbanum essential oil (1.31%), and sunflower essential oil (0.44%).
Aroma and practical use
- Use the recorded piney, camphoraceous, fresh, terpenic descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
A 2002 Artemisia annua study reported trans-pinocarveol at 11% in the essential oil and found the oil active against tested Gram-positive bacteria and fungi.
A 2002 Artemisia annua study reported trans-pinocarveol at 11% in the essential oil and found the oil active against tested Gram-positive bacteria and fungi.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2004 Pistacia vera gum oil paper reported about 1.2% trans-pinocarveol and observed concentration-dependent antibacterial and anti-yeast activity for the whole oil.
A 2004 Pistacia vera gum oil paper reported about 1.2% trans-pinocarveol and observed concentration-dependent antibacterial and anti-yeast activity for the whole oil.
This experimental finding does not establish benefit, dose or safety in people using this blend.
A 2024 Xylopia aethiopica seed-oil study identified trans-pinocarveol at 9.1% and reported strong activity of the whole oil against Candida albicans and selected bacteria, with weak DPPH antioxidant activity.
A 2024 Xylopia aethiopica seed-oil study identified trans-pinocarveol at 9.1% and reported strong activity of the whole oil against Candida albicans and selected bacteria, with weak DPPH antioxidant activity.
This experimental finding does not establish benefit, dose or safety in people using this blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedPubChem hazard summaries for trans-pinocarveol list skin- and eye-irritation classifications, so concentrated handling should assume irritancy rather than benignity.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
No constituent-specific human clinical safety dataset or IFRA-style standalone use limit for isolated trans-pinocarveol was verified in the reviewed public sources.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No direct public citation is attached to this entry.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- No human clinical studies for isolated trans-pinocarveol were located in this pass.
- The accessible activity literature is mixture-level rather than purified-constituent pharmacology.
- Constituent-specific dermal, inhalation, and repeated-exposure safety literature remains sparse in public sources.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.